Lipocine hosts KOL event for postpartum depression drug LPCN 1154

Lipocine Inc.

Virtual key opinion leader event held on June 12, 2026.
Event highlighted unmet needs in postpartum depression and clinical profile of LPCN 1154.
Presentation slides available on corporate website; no new clinical data disclosed in the 8-K.

item 8.01 item 9.01

Lipocine Inc. filing history →

Source: SEC EDGAR

accession 0001493152-26-028429

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.